Published in Genes Dev on December 01, 2001
Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell (2008) 6.07
The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J (2003) 3.91
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev (2003) 3.67
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev (2004) 3.28
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol (2004) 2.69
Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol (2002) 2.31
Role of SCF ubiquitin-ligase and the COP9 signalosome in the N gene-mediated resistance response to Tobacco mosaic virus. Plant Cell (2002) 2.21
Heterochromatin silencing of p53 target genes by a small viral protein. Nature (2010) 2.12
The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat Rev Microbiol (2008) 2.08
E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell (2009) 1.98
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91
The multiple levels of regulation by p53 ubiquitination. Cell Death Differ (2010) 1.87
F-box-like domain in the polerovirus protein P0 is required for silencing suppressor function. Proc Natl Acad Sci U S A (2006) 1.86
Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J Virol (2007) 1.80
Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol (2009) 1.77
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol (2007) 1.73
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog (2006) 1.71
Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol (2005) 1.63
The interferon stimulated gene 54 promotes apoptosis. J Biol Chem (2010) 1.58
Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol (2008) 1.57
CUL-4A is critical for early embryonic development. Mol Cell Biol (2002) 1.51
Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol Cell Biol (2004) 1.48
The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication. J Virol (2007) 1.46
Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J Virol (2005) 1.46
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci U S A (2009) 1.45
Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol (2003) 1.42
NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol (2011) 1.41
Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J Virol (2006) 1.37
Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) (2009) 1.37
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia (2006) 1.34
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol (2005) 1.33
Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol (2008) 1.32
Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proc Natl Acad Sci U S A (2009) 1.29
Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol (2013) 1.26
Ubiquitin-dependent degradation of p73 is inhibited by PML. J Exp Med (2004) 1.24
Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol (2010) 1.23
Characterization of the last subunit of the Arabidopsis COP9 signalosome: implications for the overall structure and origin of the complex. Plant Cell (2003) 1.23
Arabidopsis AtCUL3a and AtCUL3b form complexes with members of the BTB/POZ-MATH protein family. Plant Physiol (2004) 1.23
Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J Virol (2009) 1.22
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol (2008) 1.22
Strategic attack on host cell gene expression during adenovirus infection. J Virol (2003) 1.21
Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions. Proc Natl Acad Sci U S A (2006) 1.20
Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J Virol (2004) 1.19
Cullin-RING Ligases as attractive anti-cancer targets. Curr Pharm Des (2013) 1.19
Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. Proc Natl Acad Sci U S A (2010) 1.17
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol (2005) 1.17
Cullins and cancer. Genes Cancer (2010) 1.16
The adenovirus E1b55K/E4orf6 complex induces degradation of the Bloom helicase during infection. J Virol (2010) 1.15
Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J Virol (2009) 1.14
Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol (2006) 1.14
Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc Natl Acad Sci U S A (2007) 1.13
Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J (2009) 1.11
Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol (2007) 1.11
Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J Virol (2008) 1.11
A role for E1B-AP5 in ATR signaling pathways during adenovirus infection. J Virol (2008) 1.11
Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J Virol (2011) 1.09
Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J Virol (2004) 1.08
Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx. J Virol (2003) 1.08
Subversion of cell signaling by pathogens. Cold Spring Harb Perspect Biol (2012) 1.08
Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. J Virol (2008) 1.05
A viral deubiquitylating enzyme targets viral RNA-dependent RNA polymerase and affects viral infectivity. EMBO J (2011) 1.04
Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection. J Virol (2009) 1.04
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex. PLoS Pathog (2009) 1.03
The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity. J Virol (2010) 1.03
Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination. Mol Cell Biol (2004) 1.02
Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol (2012) 1.02
Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol (2008) 1.02
Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol (2010) 1.01
Distinct requirements of adenovirus E1b55K protein for degradation of cellular substrates. J Virol (2008) 1.01
Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection. J Virol (2010) 0.98
Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol Cancer (2003) 0.98
Mammalian Elongin A complex mediates DNA-damage-induced ubiquitylation and degradation of Rpb1. EMBO J (2008) 0.98
Viral subversion of nucleocytoplasmic trafficking. Traffic (2013) 0.97
Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production. J Virol (2006) 0.97
The WTX tumor suppressor enhances p53 acetylation by CBP/p300. Mol Cell (2012) 0.97
Novel molecular approaches to cystic fibrosis gene therapy. Biochem J (2005) 0.96
Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene (2012) 0.96
Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells. J Virol (2011) 0.95
Calcineurin regulates cyclin D1 accumulation in growth-stimulated fibroblasts. Mol Biol Cell (2004) 0.95
E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex. J Virol (2008) 0.95
Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase. Protein Cell (2012) 0.95
Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination. J Biol Chem (2008) 0.94
Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes. Nucleic Acids Res (2013) 0.93
Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication. J Virol (2009) 0.93
Expression of the adenovirus E4 34k oncoprotein inhibits repair of double strand breaks in the cellular genome of a 293-based inducible cell line. Nucleic Acids Res (2004) 0.93
Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases. Virology (2008) 0.92
Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. J Virol (2003) 0.92
A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication. J Virol (2009) 0.91
E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection. J Virol (2004) 0.91
Viral takeover of the host ubiquitin system. Front Microbiol (2011) 0.90
Ubiquitin ligase activities of Bombyx mori nucleopolyhedrovirus RING finger proteins. J Virol (2003) 0.89
Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase. J Biol Chem (2009) 0.89
Sp100 isoform-specific regulation of human adenovirus 5 gene expression. J Virol (2014) 0.89
Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif. Retrovirology (2013) 0.88
Adenovirus E4orf3 targets transcriptional intermediary factor 1γ for proteasome-dependent degradation during infection. J Virol (2011) 0.88
Viral and Cellular Genomes Activate Distinct DNA Damage Responses. Cell (2015) 0.87
Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex. J Virol (2014) 0.87
The emerging role of the ubiquitin proteasome in pulmonary biology and disease. Am J Respir Crit Care Med (2013) 0.87
Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins. J Virol (2014) 0.87
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (2001) 23.83
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 13.90
Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol (2000) 9.16
Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science (1999) 6.38
Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science (1999) 5.72
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69
Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem (2000) 5.58
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J (1998) 4.98
An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A (1994) 4.96
Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science (1995) 4.93
Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet (1998) 4.90
Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science (1999) 4.65
ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol Cell (1999) 4.53
Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A (2000) 4.41
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (1992) 4.36
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev (1998) 4.29
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Inhibition of transcription elongation by the VHL tumor suppressor protein. Science (1995) 4.23
Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev (1999) 4.17
cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell (1996) 4.11
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A (1999) 3.91
Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol Cell (1999) 3.58
Ubiquitin-like proteins: new wines in new bottles. Gene (2000) 3.46
Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A (1999) 3.43
Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J Virol (1984) 3.38
The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev (1999) 3.17
A new NEDD8-ligating system for cullin-4A. Genes Dev (1998) 2.82
p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev (1993) 2.74
Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene (1999) 2.67
Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem (1997) 2.64
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell (2001) 2.61
Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science (1996) 2.56
Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev (1994) 2.54
Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J (1997) 2.44
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev (1992) 2.29
JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev (1998) 2.29
Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem (1999) 2.15
Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol (1997) 2.09
Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev (1999) 2.07
Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ (2001) 2.05
Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ (1998) 2.03
Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem (2001) 1.94
The ts41 mutation in Chinese hamster cells leads to successive S phases in the absence of intervening G2, M, and G1. Cell (1992) 1.83
Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci U S A (1996) 1.78
Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function. Proc Natl Acad Sci U S A (1999) 1.78
An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp Cell Res (1999) 1.74
Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol (1997) 1.73
The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene (1998) 1.66
Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J Virol (1996) 1.65
Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun (1999) 1.63
The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex. EMBO J (1996) 1.62
Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci U S A (1997) 1.62
Mechanism and regulation of transcriptional elongation by RNA polymerase II. Curr Opin Cell Biol (1999) 1.55
Regulation of p53 function. Exp Cell Res (2001) 1.55
The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem (2000) 1.52
Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J Virol (1997) 1.37
Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J Virol (1997) 1.35
Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases. Cancer Res (2001) 1.34
Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J Virol (2001) 1.31
The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene (2000) 1.28
Isolation by a replica-plating technique of Chinese hamster temperature-sensitive cell cycle mutants. J Cell Physiol (1982) 1.25
The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA. J Virol (2000) 1.25
A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity. J Virol (2000) 1.24
p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J Virol (1997) 1.21
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein. J Virol (2001) 1.16
The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1-independent mechanism. J Virol (2001) 1.11
Inhibition of cell-proliferation by an adenovirus vector expressing the human wild type-p53 protein. Int J Oncol (1993) 1.08
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J Virol (2000) 1.04
On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett (1997) 1.03
An arginine-faced amphipathic alpha helix is required for adenovirus type 5 e4orf6 protein function. J Virol (1999) 1.02
Adenovirus late gene expression does not require a Rev-like nuclear RNA export pathway. J Virol (2000) 0.99
p27 destruction: Cks1 pulls the trigger. Nat Cell Biol (2001) 0.95
Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla. Am J Physiol (1995) 0.95
Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res (1997) 0.95
The elongin B ubiquitin homology domain. Identification of Elongin B sequences important for interaction with Elongin C. J Biol Chem (1999) 0.92
VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule. Am J Physiol (1999) 0.83
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol (2000) 9.16
Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science (1999) 6.38
Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science (1999) 5.72
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A (1996) 5.69
p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature (1997) 5.42
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (1999) 5.33
E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A (1994) 5.11
Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science (1995) 4.93
Tumour suppression by the human von Hippel-Lindau gene product. Nat Med (1995) 4.71
Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science (1999) 4.65
Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56
Exposed protein on the intact human erythrocyte. Biochemistry (1971) 4.56
Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A (2000) 4.41
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev (1998) 4.29
The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell (1991) 4.24
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Inhibition of transcription elongation by the VHL tumor suppressor protein. Science (1995) 4.23
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci (2001) 3.85
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development (1996) 3.84
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83
Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72
General initiation factors for RNA polymerase II. Annu Rev Biochem (1993) 3.69
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
The arrangement of proteins in the human erythrocyte membrane. Biochem Biophys Res Commun (1970) 3.54
Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science (1995) 3.53
Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol (1996) 3.50
An RNA polymerase II elongation factor encoded by the human ELL gene. Science (1996) 3.46
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer (2000) 3.46
Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A (1999) 3.43
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci (1997) 3.41
A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol (1993) 3.38
Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol Cell Biol (1998) 3.30
IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron (1997) 3.21
Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci U S A (1998) 3.18
Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol Cell Biol (1988) 3.07
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev (1998) 3.01
Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev (2001) 2.96
Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol (1994) 2.95
von Hippel-Lindau disease. Medicine (Baltimore) (1997) 2.89
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol (2001) 2.88
Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature (1995) 2.87
p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol (1997) 2.84
Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology (1985) 2.80
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet (2001) 2.79
Control of elongation by RNA polymerase II. Trends Biochem Sci (2000) 2.79
The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev (1999) 2.78
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell (1998) 2.77
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet (2000) 2.69
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
A DNA primase activity associated with DNA polymerase alpha from Drosophila melanogaster embryos. Proc Natl Acad Sci U S A (1982) 2.53
Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature (1993) 2.43
Identification of human adenovirus early region 1 products by using antisera against synthetic peptides corresponding to the predicted carboxy termini. J Virol (1983) 2.35
A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci (1998) 2.28
Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc Natl Acad Sci U S A (1990) 2.27
Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem (2001) 2.23
Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney Int (2006) 2.22
Use of lactoperoxidase catalyzed iodination in immunochemical studies. Immunochemistry (1971) 2.19
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci U S A (1995) 2.17
Peroxidase-catalyzed halogenation. Annu Rev Biochem (1976) 2.16
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol (2001) 2.14
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature (2000) 2.10
Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol (1997) 2.09
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol (1998) 2.04
Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol (1997) 2.02
MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol (1999) 2.00
The RNA polymerase II general elongation factors. Trends Biochem Sci (1996) 1.99
The transcription factor E2F-1 is a downstream target of RB action. Mol Cell Biol (1995) 1.97
The chick fibroblast cell surface after transformation by Rous sarcoma virus. Cold Spring Harb Symp Quant Biol (1975) 1.94
The determination of the exposed proteins on membranes by the use of lactoperoxidase. Methods Enzymol (1974) 1.94
Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem (2001) 1.94
An RNA polymerase II transcription system from rat liver. Purification of an essential component. J Biol Chem (1987) 1.90